Indero is proud to announce the successful completion of an internally funded study that introduces a novel approach to ...

The FDA has put a clinical hold on a Tenaya Therapeutics gene therapy study | The FDA has put a clinical hold on a Tenaya ...

SonoThera™, a biotechnology company dedicated to treating the root cause of human diseases by developing the next generation ...

The FDA’s Marty Makary and Vinay Prasad have laid out a path for CRISPR treatments on demand. An expert weighs in on what it ...

Although heart cells and skin cells contain identical instructions for creating proteins encoded in their DNA, they're able ...

Approach that uses cell’s own strategy of liquid-liquid phase separation protects synthetic modifications from being washed away by the tide of cell growth.

Study finds protein traits and CHO-cell gene programs drive therapeutic protein yields, guiding biomanufacturing.

MavriX Bio, a clinical-stage biotechnology company focused on the development of transformative genetic therapies for Angelman syndrome (AS), today announced that the first patient has been dosed in ...

SkylineDx, an innovative diagnostics company specializing in the research and development of molecular diagnostics for oncology, ...

On November 6, 2025, Shanghai, China, CorrectSequence Therapeutics Co., Ltd. (Correctseq), a clinical-stage biotechnology ...

As a full-stack Gene Factory, Tsingke Biotech demonstrated capabilities spanning DNA/RNA synthesis, antibody expression, and nucleic acid process development. Its integrated platform connects ...